Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Statistics

Total Valuation

BOM:524731 has a market cap or net worth of INR 4.53 billion. The enterprise value is 4.45 billion.

Market Cap	4.53B
Enterprise Value	4.45B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Jul 11, 2025

Share Statistics

BOM:524731 has 4.41 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	4.41M
Shares Outstanding	4.41M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	55.12%
Owned by Institutions (%)	1.19%
Float	1.26M

Valuation Ratios

The trailing PE ratio is 13.72.

PE Ratio	13.72
Forward PE	n/a
PS Ratio	2.85
PB Ratio	2.47
P/TBV Ratio	2.48
P/FCF Ratio	n/a
P/OCF Ratio	16.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.70, with an EV/FCF ratio of -264.78.

EV / Earnings	13.47
EV / Sales	2.80
EV / EBITDA	10.70
EV / EBIT	11.48
EV / FCF	-264.78

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.01.

Current Ratio	2.17
Quick Ratio	1.56
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	-1.02
Interest Coverage	105.74

Financial Efficiency

Return on equity (ROE) is 19.37% and return on invested capital (ROIC) is 17.02%.

Return on Equity (ROE)	19.37%
Return on Assets (ROA)	12.39%
Return on Invested Capital (ROIC)	17.02%
Return on Capital Employed (ROCE)	20.58%
Weighted Average Cost of Capital (WACC)	6.36%
Revenue Per Employee	2.04M
Profits Per Employee	423,611
Employee Count	779
Asset Turnover	0.81
Inventory Turnover	3.26

Taxes

In the past 12 months, BOM:524731 has paid 128.63 million in taxes.

Income Tax	128.63M
Effective Tax Rate	28.05%

Stock Price Statistics

The stock price has decreased by -10.04% in the last 52 weeks. The beta is 0.38, so BOM:524731's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	-10.04%
50-Day Moving Average	1,128.02
200-Day Moving Average	1,159.24
Relative Strength Index (RSI)	41.89
Average Volume (20 Days)	817

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524731 had revenue of INR 1.59 billion and earned 329.99 million in profits. Earnings per share was 74.77.

Revenue	1.59B
Gross Profit	1.28B
Operating Income	387.23M
Pretax Income	458.63M
Net Income	329.99M
EBITDA	410.87M
EBIT	387.23M
Earnings Per Share (EPS)	74.77

Balance Sheet

The company has 96.48 million in cash and 17.08 million in debt, with a net cash position of 79.41 million or 17.99 per share.

Cash & Cash Equivalents	96.48M
Total Debt	17.08M
Net Cash	79.41M
Net Cash Per Share	17.99
Equity (Book Value)	1.83B
Book Value Per Share	414.40
Working Capital	244.49M

Cash Flow

In the last 12 months, operating cash flow was 282.46 million and capital expenditures -299.25 million, giving a free cash flow of -16.79 million.

Operating Cash Flow	282.46M
Capital Expenditures	-299.25M
Free Cash Flow	-16.79M
FCF Per Share	-3.81

Margins

Gross margin is 80.42%, with operating and profit margins of 24.35% and 20.75%.

Gross Margin	80.42%
Operating Margin	24.35%
Pretax Margin	28.84%
Profit Margin	20.75%
EBITDA Margin	25.84%
EBIT Margin	24.35%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 18.00, which amounts to a dividend yield of 1.70%.

Dividend Per Share	18.00
Dividend Yield	1.70%
Dividend Growth (YoY)	17.65%
Years of Dividend Growth	5
Payout Ratio	24.21%
Buyback Yield	-0.01%
Shareholder Yield	1.69%
Earnings Yield	7.29%
FCF Yield	-0.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4